title: Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.
authors.affiliation: Hematology Department, Hôpital Edouard Herriot, 5 place d'Arsonval 69437 Lyon, Cédex 03 France.
authors.forename: Thomas
authors.initials: T
authors.lastname: Prebet
authors.forename: Isabelle
authors.initials: I
authors.lastname: Tigaud
authors.forename: Sandrine
authors.initials: S
authors.lastname: Hayette
authors.forename: Gilles
authors.initials: G
authors.lastname: Clapisson
authors.forename: Irène
authors.initials: I
authors.lastname: Philip
authors.forename: Mauricette
authors.initials: M
authors.lastname: Michallet
authors.forename: Franck E
authors.initials: FE
authors.lastname: Nicolini
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001549:Benzamides; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000235:genetics; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D000068877:Imatinib Mesylate; D007372:Interferons / Q000627:therapeutic use; D000078224:Lenograstim; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics / Q000601:surgery*; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy / Q000235:genetics / Q000601:surgery*; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000494:pharmacology; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D000078224:Lenograstim; D000068877:Imatinib Mesylate; D007372:Interferons; D016044:Fusion Proteins, bcr-abl